KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - Other
Ratios

Bristol Myers Squibb (BMY) Other Gross PP&E Adjustments (2016 - 2025)

Bristol Myers Squibb (BMY) has disclosed Other Gross PP&E Adjustments for 17 consecutive years, with -$1.4 billion as the latest value for Q4 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments fell 34.05% to -$1.4 billion in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.4 billion, a 34.05% decrease, with the full-year FY2025 number at -$1.4 billion, down 34.05% from a year prior.
  • Other Gross PP&E Adjustments was -$1.4 billion for Q4 2025 at Bristol Myers Squibb, up from -$1.4 billion in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of -$678.0 million in Q2 2022 to a low of -$1.4 billion in Q3 2025.
  • A 5-year average of -$1.0 billion and a median of -$1.1 billion in 2023 define the central range for Other Gross PP&E Adjustments.
  • Peak YoY movement for Other Gross PP&E Adjustments: increased 19.0% in 2022, then tumbled 67.13% in 2023.
  • Bristol Myers Squibb's Other Gross PP&E Adjustments stood at -$750.0 million in 2021, then crashed by 41.07% to -$1.1 billion in 2022, then decreased by 16.07% to -$1.2 billion in 2023, then rose by 13.44% to -$1.1 billion in 2024, then crashed by 34.05% to -$1.4 billion in 2025.
  • Per Business Quant, the three most recent readings for BMY's Other Gross PP&E Adjustments are -$1.4 billion (Q4 2025), -$1.4 billion (Q3 2025), and -$1.1 billion (Q2 2025).